Authors: MORTON AJ GOOLEY T HANSEN JA APPELBAUM FR BRUEMMER B BJERKE JW CLIFT R MARTIN PJ PETERSDORF EW SANDERS JE STORB R SULLIVAN KM WOOLFREY A ANASETTI C

Citation: Aj. Morton et al., ASSOCIATION BETWEEN PRETRANSPLANT INTERFERON-ALPHA AND OUTCOME AFTER UNRELATED DONOR MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE, Blood, 92(2), 1998, pp. 394-401

Authors: MORTON AJ GOOLEY T HANSEN JA APPELBAUM FR BJERKE JW CLIFT R MARTIN PJ PETERSDORF EW SANDERS JE STORB R SULLIVAN KM ANASETTI C

Citation: Aj. Morton et al., IMPACT OF PRETRANSPLANT INTERFERON-ALPHA (IFN-ALPHA) ON OUTCOME OF UNRELATED DONOR MARROW TRANSPLANTS FOR CHRONIC MYELOID-LEUKEMIA (CML) INFIRST CHRONIC PHASE, Blood, 90(10), 1997, pp. 536-536

Authors: SIERRA J STORER B HANSEN JA BJERKE JW MARTIN PJ PETERSDORF EW APPELBAUM FR BRYANT E CHAUNCEY TR SALE G SANDERS JE STORB R SULLIVAN KM ANASETTI C

Citation: J. Sierra et al., TRANSPLANTATION OF MARROW-CELLS FROM UNRELATED DONORS FOR TREATMENT OF HIGH-RISK ACUTE-LEUKEMIA - THE EFFECT OF LEUKEMIC BURDEN, DONOR HLA-MATCHING, AND MARROW CELL DOSE, Blood, 89(11), 1997, pp. 4226-4235

Authors: BJERKE JW LORENZ J MARTIN PJ STORB R HANSEN JA ANASETTI C

Citation: Jw. Bjerke et al., TREATMENT OF GRAFT FAILURE WITH ANTI-CD3 ANTIBODY BC3, GLUCOCORTICOIDS AND INFUSION OF DONOR HEMATOPOIETIC-CELLS, Blood, 86(10), 1995, pp. 415-415

Authors: BJERKE JW MEYERS JD BOWDEN RA

Citation: Jw. Bjerke et al., HEPATOSPLENIC CANDIDIASIS - A CONTRAINDICATION TO MARROW TRANSPLANTATION, Blood, 84(8), 1994, pp. 2811-2814